What genetic tests does NCCN recommend for me

I'll help explain the genetic testing recommendations for Stage IV prostate cancer, according to trusted guidelines.

According to the current NCCN Guidelines for Prostate Cancer (2024), genetic testing is recommended for all patients with metastatic prostate cancer. Specifically, they recommend:

1. Germline Testing (testing your inherited genes):

• NCCN strongly recommends germline genetic testing for all patients with metastatic prostate cancer
• Key genes to test include: BRCA1, BRCA2, ATM, PALB2, CHEK2, and other DNA repair genes
• This testing is important because it can: • Guide treatment choices • Identify if you might benefit from specific treatments (like PARP inhibitors) • Help identify cancer risks for family members

1. Tumor Testing (testing the cancer cells): The American Society of Clinical Oncology (ASCO) guidelines recommend:

• Somatic (tumor) testing for mutations in DNA repair genes
• Testing for microsatellite instability (MSI) status
• These results can help determine if certain targeted therapies might be effective

Important notes:

• According to the National Cancer Institute (NCI), genetic test results may influence: • Treatment selection • Clinical trial eligibility • Family cancer screening recommendations

Always discuss genetic testing with your healthcare team, as they can:

• Order appropriate tests
• Interpret results in context of your specific situation
• Refer you to genetic counseling if needed
• Help you understand how results might impact your treatment plan

Would you like me to explain more about any specific aspect of genetic testing?